BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25550768)

  • 1. BRAF mutation as a potential marker to identify the proximal colon serrated polyps with malignant potential.
    Fu X; Zhang X
    Int J Clin Exp Pathol; 2014; 7(11):7319-22. PubMed ID: 25550768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign serrated colorectal fibroblastic polyps/intramucosal perineuriomas are true mixed epithelial-stromal polyps (hybrid hyperplastic polyp/mucosal perineurioma) with frequent BRAF mutations.
    Agaimy A; Stoehr R; Vieth M; Hartmann A
    Am J Surg Pathol; 2010 Nov; 34(11):1663-71. PubMed ID: 20962618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
    Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
    J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serrated epithelial colorectal polyps (hyperplastic polyps, sessile serrated adenomas) with perineurial stroma: Clinicopathological and molecular analysis of a new series.
    Erlenbach-Wünsch K; Bihl M; Hartmann A; Groisman GM; Vieth M; Agaimy A
    Ann Diagn Pathol; 2018 Aug; 35():48-52. PubMed ID: 29747061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.
    Spring KJ; Zhao ZZ; Karamatic R; Walsh MD; Whitehall VL; Pike T; Simms LA; Young J; James M; Montgomery GW; Appleyard M; Hewett D; Togashi K; Jass JR; Leggett BA
    Gastroenterology; 2006 Nov; 131(5):1400-7. PubMed ID: 17101316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and molecular characterisation of the sessile serrated adenoma in a subset of the Chinese population.
    Qiu Y; Fu X; Zhang W; Xu Y; Xiao L; Chen X; Shi L; Zhou X; Xia G; Peng Y; Deng M
    J Clin Pathol; 2014 Jun; 67(6):491-8. PubMed ID: 24570042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic and molecular analyses of colonic perineurial-like proliferations in serrated polyps: perineurial-like stromal proliferations are seen in sessile serrated adenomas.
    Pai RK; Mojtahed A; Rouse RV; Soetikno RM; Kaltenbach T; Ma L; Arber DA; Plesec TP; Goldblum JR; Pai RK
    Am J Surg Pathol; 2011 Sep; 35(9):1373-80. PubMed ID: 21836484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cautionary note on the immunohistochemical detection of BRAF v600e mutations in serrated lesions of the colon.
    Panarelli NC; Weidner AS; Yantiss RK; Chen YT
    Mod Pathol; 2015 May; 28(5):740-1. PubMed ID: 25925285
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular and histologic considerations in the assessment of serrated polyps.
    Yang HM; Mitchell JM; Sepulveda JL; Sepulveda AR
    Arch Pathol Lab Med; 2015 Jun; 139(6):730-41. PubMed ID: 26030242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
    O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
    Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Examination is Highly Sensitive and Specific for Detection of the V600E BRAF Mutation in Colorectal Serrated Lesions.
    Yamada N; Eizuka M; Sugimoto R; Tanaka Y; Yanagawa N; Yamano H; Suzuki H; Matsumoto T; Sugai T
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):446-453. PubMed ID: 33306619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions.
    Tsai JH; Cheng CH; Chen CC; Lin YL; Lin LI; Chen ML; Liau JY
    Histopathology; 2016 May; 68(6):810-8. PubMed ID: 26496853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
    Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
    Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma.
    Janjua HG; Høgdall E; Linnemann D
    APMIS; 2015 Apr; 123(4):298-304. PubMed ID: 25708741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
    Kim YH; Kakar S; Cun L; Deng G; Kim YS
    Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
    Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
    Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.